Your session is about to expire
← Back to Search
mRNA-1083 Vaccine for Respiratory Infections
This trial studies the safety and effectiveness of two vaccines against influenza and SARS-CoV-2, in adults aged 50-65 and over 65.
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are there any vacancies in this clinical trial for participants?
"Sadly, this medical trial is not currently enrolling patients. Although it was initially posted on October 19th 2023 and updated lastly on 18th of the same month, no new participants are being sought out at present. Nevertheless, 255 other studies have vacancies available for those interested in participating."
How many healthcare facilities are currently undertaking this clinical trial?
"Over 170 facilities are participating in the trial, including Accel Research Site - Achieve - Birmingham from Birmingham and Cullman Clinical Trials from Cullman. Additionally, Lenzmeier Family Medicine - CCT - PPDS located in Glendale is also part of the study's current recruitment campaign."
Is there a risk of adverse effects from the concurrent administration of an Influenza Vaccine and COVID-19 Vaccine in Cohort A2?
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends